Late urinary toxicity modeling after stereotactic body radiotherapy (SBRT) in the definitive treatment of localized prostate cancer (original) (raw)
Dose-volume analysis and the temporal nature of toxicity with stereotactic body radiation therapy for prostate cancer
Mack Roach
Practical Radiation Oncology, 2015
View PDFchevron_right
Predictive Factors for Urinary Toxicity from a Multi-Center Trial of Stereotactic Body Radiation Therapy for Prostate Cancer
Najeeb Mohideen
International Journal of Radiation Oncology*Biology*Physics, 2018
View PDFchevron_right
Dosimetric predictors of toxicity and quality of life following prostate stereotactic ablative radiotherapy
Alexandre Mamedov
Radiotherapy and Oncology, 2020
View PDFchevron_right
Stereotactic Body Radiotherapy for Localized Prostate Cancer: Interim Results of a Prospective Phase II Clinical Trial
Cristian Cotrutz
International Journal of Radiation Oncology Biology Physics, 2009
View PDFchevron_right
Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer
Harcharan Gill
2012
View PDFchevron_right
Predictors of acute urinary symptom flare following stereotactic body radiation therapy (SBRT) in the definitive treatment of localized prostate cancer
Anatoly Dritschilo
Acta Oncologica, 2017
View PDFchevron_right
Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer
Donald Fuller
JAMA Network Open, 2019
View PDFchevron_right
Urinary toxicity after high dose intensity modulated radiotherapy as primary therapy for prostate cancer
Valérie Fonteyne
Radiotherapy and Oncology, 2009
View PDFchevron_right
Stereotactic Body Radiotherapy for High-Risk Prostate Cancer: Preliminary Toxicity Results of a Phase 2 Trial
Donald Fuller
International Journal of Radiation Oncology*Biology*Physics, 2017
View PDFchevron_right
Correlation Between Acute and Late Toxicity in 973 Prostate Cancer Patients Treated With Three-Dimensional Conformal External Beam Radiotherapy
Cristiana Fodor
International Journal of Radiation Oncology*Biology*Physics, 2010
View PDFchevron_right
Predictive models of toxicity with external radiotherapy for prostate cancer: Clinical issues
Tiziana Rancati
Cancer, 2009
View PDFchevron_right
Relationships between bladder dose–volume/surface histograms and acute urinary toxicity after radiotherapy for prostate cancer
Tiziana Rancati
Radiotherapy and Oncology, 2014
View PDFchevron_right
Stereotactic body radiotherapy with a focal boost to the MRI-visible tumor as monotherapy for low- and intermediate-risk prostate cancer: early results
Chris Bangma
Radiation Oncology, 2013
View PDFchevron_right
Toxicity Profile With a Large Prostate Volume After External Beam Radiotherapy for Localized Prostate Cancer
Michael Pinkawa
International Journal of Radiation Oncology*Biology*Physics, 2008
View PDFchevron_right
A Phase II Study of Stereotactic Body Radiation Therapy for Low-Intermediate-High-Risk Prostate Cancer Using Helical Tomotherapy: Dose-Volumetric Parameters Predicting Early Toxicity
inmaculada barrera
Frontiers in oncology, 2014
View PDFchevron_right
Clinical Factors Predicting Late Severe Urinary Toxicity After Postoperative Radiotherapy for Prostate Carcinoma: A Single-Institute Analysis of 742 Patients
Filippo Alongi
International Journal of Radiation Oncology*Biology*Physics, 2012
View PDFchevron_right
Stereotactic Body Radiation Therapy for Intermediate-risk Organ-confined Prostate Cancer: Interim Toxicity and Quality of Life Outcomes From a Multi-institutional Study
Najeeb Mohideen
International Journal of Radiation Oncology*Biology*Physics, 2012
View PDFchevron_right
Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience
viola chen
Radiation Oncology, 2013
View PDFchevron_right
Stereotactic Body Radiation Therapy Versus Intensity-Modulated Radiation Therapy for Prostate Cancer: Comparison of Toxicity
James Yu
Journal of Clinical Oncology, 2014
View PDFchevron_right
Multicenter Trial of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: Survival and Toxicity Endpoints
Najeeb Mohideen
International Journal of Radiation Oncology*Biology*Physics, 2018
View PDFchevron_right
Toxicity outcome in patients treated with modulated arc radiotherapy for localized prostate cancer
Maria Gonzalez
Reports of Practical Oncology & Radiotherapy, 2014
View PDFchevron_right
Late toxicity following conventional radiotherapy for prostate cancer: analysis of the EORTC trial 22863
alfredo zurlo
European Journal of Cancer, 2004
View PDFchevron_right
Predicting Radiotherapy Impact on Late Bladder Toxicity in Prostate Cancer Patients: An Observational Study
F. Catucci
Cancers
View PDFchevron_right
Dose–response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control
Jesus Juarez
Radiotherapy and Oncology, 2021
View PDFchevron_right
Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy
Tomas Kron
Radiation Oncology, 2011
View PDFchevron_right
Late Toxicity After Intensity-Modulated Radiation Therapy for Localized Prostate Cancer: An Exploration of Dose–Volume Histogram Parameters to Limit Genitourinary and Gastrointestinal Toxicity
david lopera correa
International Journal of Radiation Oncology*Biology*Physics, 2012
View PDFchevron_right